Arrayit Corporation
http://www.arrayit.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Arrayit Corporation
When Pandemic Ends, EUA Recipients May Face Litigation And Enforcement Actions
Manufacturers face risk of whistle-blower suits and government enforcement actions when emergency use authorizations expire and pandemic recedes, attorneys say, but interaction with FDA and documentation may mitigate risk.